CARA THERAPEUTICS INC (CARAXXXX)
Institutional ownership reported to the SEC as of Q4 2024, across 25 quarters.
1
Reporting holders
$7.2K
Reported value
0.0%
Held as options
-63
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Rathbones Group PLC | $7.2K | 20,164 | 0.00% | 25q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2024 | 1 | $7.2K | 20,164 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 64 | $4.1M | 13,364,109 | 6 | 4 | 25 | 0.0% |
| Q2 2024 | 75 | $4.4M | 17,184,639 | 13 | 13 | 22 | 0.3% |
| Q1 2024 | 90 | $20.3M | 22,033,388 | 10 | 19 | 27 | 0.2% |
| Q4 2023 | 101 | $17.3M | 23,175,359 | 13 | 28 | 27 | 0.3% |
| Q3 2023 | 108 | $43.3M | 25,762,788 | 14 | 29 | 35 | 0.3% |
| Q2 2023 | 120 | $78.6M | 27,586,944 | 20 | 41 | 32 | 0.4% |
| Q1 2023 | 130 | $141.1M | 28,625,707 | 21 | 31 | 43 | 0.5% |
| Q4 2022 | 119 | $280.8M | 25,973,244 | 19 | 41 | 29 | 0.7% |
| Q3 2022 | 158 | $325.5M | 34,569,975 | 9 | 68 | 44 | 0.6% |
| Q2 2022 | 174 | $321.4M | 34,815,058 | 24 | 46 | 57 | 1.1% |
| Q1 2022 | 181 | $389.6M | 31,731,218 | 24 | 44 | 68 | 1.0% |
| Q4 2021 | 181 | $381.9M | 30,660,740 | 31 | 46 | 50 | 2.2% |
| Q3 2021 | 168 | $469.6M | 29,598,558 | 25 | 48 | 52 | 2.6% |
| Q2 2021 | 172 | $453.1M | 31,119,943 | 41 | 52 | 50 | 2.0% |
| Q1 2021 | 168 | $761.8M | 32,409,925 | 31 | 44 | 48 | 7.6% |
| Q4 2020 | 154 | $515.9M | 32,712,930 | 15 | 44 | 48 | 4.1% |
| Q3 2020 | 159 | $433.3M | 33,401,695 | 28 | 31 | 44 | 1.9% |
| Q2 2020 | 146 | $573.5M | 32,739,306 | 35 | 44 | 28 | 2.4% |
| Q1 2020 | 134 | $434.5M | 32,273,496 | 16 | 33 | 43 | 1.9% |
| Q4 2019 | 152 | $529.0M | 31,906,528 | 23 | 47 | 37 | 2.8% |
| Q3 2019 | 145 | $573.3M | 30,530,011 | 32 | 50 | 34 | 2.6% |
| Q2 2019 | 128 | $648.2M | 26,763,710 | 15 | 47 | 28 | 11.2% |
| Q1 2019 | 138 | $466.8M | 22,309,158 | 22 | 33 | 43 | 6.2% |
| Q4 2018 | 134 | $328.1M | 24,621,166 | 4 | 4 | 2 | 2.5% |